113 related articles for article (PubMed ID: 22659407)
1. Long-lasting efficacy of the cognitive enhancer cytotoxic necrotizing factor 1.
Borrelli S; Musilli M; Martino A; Diana G
Neuropharmacology; 2013 Jan; 64():74-80. PubMed ID: 22659407
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of learning and memory after activation of cerebral Rho GTPases.
Diana G; Valentini G; Travaglione S; Falzano L; Pieri M; Zona C; Meschini S; Fabbri A; Fiorentini C
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):636-41. PubMed ID: 17202256
[TBL] [Abstract][Full Text] [Related]
3. The Rho GTPase activating CNF1 improves associative working memory for object-in-place.
De Viti S; Martino A; Musilli M; Fiorentini C; Diana G
Behav Brain Res; 2010 Sep; 212(1):78-83. PubMed ID: 20362628
[TBL] [Abstract][Full Text] [Related]
4. The Rac GTPase-activating bacterial protein toxin CNF1 induces analgesia up-regulating mu-opioid receptors.
Pavone F; Luvisetto S; Marinelli S; Straface E; Fabbri A; Falzano L; Fiorentini C; Malorni W
Pain; 2009 Sep; 145(1-2):219-29. PubMed ID: 19608345
[TBL] [Abstract][Full Text] [Related]
5. Behavioral effects of Rho GTPase modulation in a model of Alzheimer's disease.
Musilli M; Nicolia V; Borrelli S; Scarpa S; Diana G
Behav Brain Res; 2013 Jan; 237():223-9. PubMed ID: 23026376
[TBL] [Abstract][Full Text] [Related]
6. The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant properties.
Munro P; Flatau G; Anjuère F; Hofman V; Czerkinsky C; Lemichez E
Vaccine; 2005 Apr; 23(20):2551-6. PubMed ID: 15780436
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic necrotizing factor 1 hinders skeletal muscle differentiation in vitro by perturbing the activation/deactivation balance of Rho GTPases.
Travaglione S; Messina G; Fabbri A; Falzano L; Giammarioli AM; Grossi M; Rufini S; Fiorentini C
Cell Death Differ; 2005 Jan; 12(1):78-86. PubMed ID: 15514676
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of the Rho GTPase modulator CNF1 in a model of Parkinson's disease.
Musilli M; Ciotti MT; Pieri M; Martino A; Borrelli S; Dinallo V; Diana G
Neuropharmacology; 2016 Oct; 109():357-365. PubMed ID: 27350290
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic necrotizing factor-2 of Escherichia coli alters the morphology of cultured hippocampal neurons.
Boutillier S; Rapp J; Staeb T; Olenik C; Schmidt G; Meyer DK; Leemhuis J
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):513-9. PubMed ID: 14605794
[TBL] [Abstract][Full Text] [Related]
10. Nicotine improves performance in an attentional set shifting task in rats.
Allison C; Shoaib M
Neuropharmacology; 2013 Jan; 64():314-20. PubMed ID: 22776507
[TBL] [Abstract][Full Text] [Related]
11. CNF1 improves astrocytic ability to support neuronal growth and differentiation in vitro.
Malchiodi-Albedi F; Paradisi S; Di Nottia M; Simone D; Travaglione S; Falzano L; Guidotti M; Frank C; Cutarelli A; Fabbri A; Fiorentini C
PLoS One; 2012; 7(4):e34115. PubMed ID: 22523545
[TBL] [Abstract][Full Text] [Related]
12. Nicotine facilitates memory consolidation in perceptual learning.
Beer AL; Vartak D; Greenlee MW
Neuropharmacology; 2013 Jan; 64():443-51. PubMed ID: 22749926
[TBL] [Abstract][Full Text] [Related]
13. Activation and proteasomal degradation of rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response.
Munro P; Flatau G; Doye A; Boyer L; Oregioni O; Mege JL; Landraud L; Lemichez E
J Biol Chem; 2004 Aug; 279(34):35849-57. PubMed ID: 15152002
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Rho GTPases rescues brain mitochondrial dysfunction, cognitive deficits and aberrant synaptic plasticity in female mice modeling Rett syndrome.
De Filippis B; Valenti D; Chiodi V; Ferrante A; de Bari L; Fiorentini C; Domenici MR; Ricceri L; Vacca RA; Fabbri A; Laviola G
Eur Neuropsychopharmacol; 2015 Jun; 25(6):889-901. PubMed ID: 25890884
[TBL] [Abstract][Full Text] [Related]
15. Piccolo knockdown-induced impairments of spatial learning and long-term potentiation in the hippocampal CA1 region.
Ibi D; Nitta A; Ishige K; Cen X; Ohtakara T; Nabeshima T; Ito Y
Neurochem Int; 2010 Jan; 56(1):77-83. PubMed ID: 19766155
[TBL] [Abstract][Full Text] [Related]
16. Structure of the Rho-activating domain of Escherichia coli cytotoxic necrotizing factor 1.
Buetow L; Flatau G; Chiu K; Boquet P; Ghosh P
Nat Struct Biol; 2001 Jul; 8(7):584-8. PubMed ID: 11427886
[TBL] [Abstract][Full Text] [Related]
17. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1.
Schmidt G; Sehr P; Wilm M; Selzer J; Mann M; Aktories K
Nature; 1997 Jun; 387(6634):725-9. PubMed ID: 9192900
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of modafinil on emotional memory in mice.
Fernandes HA; Zanin KA; Patti CL; Wuo-Silva R; Carvalho RC; Fernandes-Santos L; Bittencourt LR; Tufik S; Frussa-Filho R
Neuropharmacology; 2013 Jan; 64():365-70. PubMed ID: 22771974
[TBL] [Abstract][Full Text] [Related]
19. Activation of Rho GTPases triggers structural remodeling and functional plasticity in the adult rat visual cortex.
Cerri C; Fabbri A; Vannini E; Spolidoro M; Costa M; Maffei L; Fiorentini C; Caleo M
J Neurosci; 2011 Oct; 31(42):15163-72. PubMed ID: 22016550
[TBL] [Abstract][Full Text] [Related]
20. The E. coli CNF1 as a pioneering therapy for the central nervous system diseases.
Travaglione S; Loizzo S; Ballan G; Fiorentini C; Fabbri A
Toxins (Basel); 2014 Jan; 6(1):270-82. PubMed ID: 24402235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
